Cargando…

Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration

Methylparaben, ethylparaben, and propylparaben are widely used as preservatives in food, cosmetics, and pharmaceutical products. Parabens are also known to bind the estrogen receptor and induce weak estrogen activity in laboratory bioassays. Many OTC topical medications contain one or more parabens...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Brianna, Ma, Peng, Zhang, Changde, Wiese, Thomas E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089598/
http://dx.doi.org/10.1210/jendso/bvab048.995
_version_ 1783687077083217920
author Allen, Brianna
Ma, Peng
Zhang, Changde
Wiese, Thomas E
author_facet Allen, Brianna
Ma, Peng
Zhang, Changde
Wiese, Thomas E
author_sort Allen, Brianna
collection PubMed
description Methylparaben, ethylparaben, and propylparaben are widely used as preservatives in food, cosmetics, and pharmaceutical products. Parabens are also known to bind the estrogen receptor and induce weak estrogen activity in laboratory bioassays. Many OTC topical medications contain one or more parabens as preservative ingredients. In this study, we surveyed the estrogen activity of extracts from OTC topical medications and tested the hypothesis that a combined threshold concentration of particular parabens is required to induce estrogen activity in human breast cancer cell bioassays. Ethanol extracts (1 gm:1 ml) were prepared from OTC topical medications containing parabens (including: Olay Quench Lotion, CeraVe Daily Moisturizing Lotion and Cortizon-10 Lotion). The estrogen agonist and antagonist activity of each extract was determined using the T47dkbluc estrogen reporter gene and the MCF-7 E3 estrogen responsive proliferation assays. The extracts from Olay Quench Lotion and CeraVe Daily Moisturizing Lotion induced estrogen agonist activity in the MCF-7 proliferation assay. The extract from the Cortizon-10 Lotion did not induce significant estrogen activity. The product ingredients of each OTC topical medications tested listed ethyl and propyl parabens while the Olay Quench Lotion also contained the least estrogenic paraben methylparaben. We propose that the estrogenic potential of OTC topical medications can be estimated with LC-MS analysis determination of paraben content and concentration. This study illustrates that measurable estrogen activity from OTC topical medications requires the presence of estrogenic parabens (ethyl and propyl) at total concentrations that exceed a threshold. Thus, estrogen activity depends on the type and concentration of paraben present in the OTC topical products. While the capacity for these OTC topical medications to induce estrogen activity in individuals using the products is unclear, consumers may benefit from more information about the paraben type and concentration present.
format Online
Article
Text
id pubmed-8089598
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-80895982021-05-06 Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration Allen, Brianna Ma, Peng Zhang, Changde Wiese, Thomas E J Endocr Soc Endocrine Disruption Methylparaben, ethylparaben, and propylparaben are widely used as preservatives in food, cosmetics, and pharmaceutical products. Parabens are also known to bind the estrogen receptor and induce weak estrogen activity in laboratory bioassays. Many OTC topical medications contain one or more parabens as preservative ingredients. In this study, we surveyed the estrogen activity of extracts from OTC topical medications and tested the hypothesis that a combined threshold concentration of particular parabens is required to induce estrogen activity in human breast cancer cell bioassays. Ethanol extracts (1 gm:1 ml) were prepared from OTC topical medications containing parabens (including: Olay Quench Lotion, CeraVe Daily Moisturizing Lotion and Cortizon-10 Lotion). The estrogen agonist and antagonist activity of each extract was determined using the T47dkbluc estrogen reporter gene and the MCF-7 E3 estrogen responsive proliferation assays. The extracts from Olay Quench Lotion and CeraVe Daily Moisturizing Lotion induced estrogen agonist activity in the MCF-7 proliferation assay. The extract from the Cortizon-10 Lotion did not induce significant estrogen activity. The product ingredients of each OTC topical medications tested listed ethyl and propyl parabens while the Olay Quench Lotion also contained the least estrogenic paraben methylparaben. We propose that the estrogenic potential of OTC topical medications can be estimated with LC-MS analysis determination of paraben content and concentration. This study illustrates that measurable estrogen activity from OTC topical medications requires the presence of estrogenic parabens (ethyl and propyl) at total concentrations that exceed a threshold. Thus, estrogen activity depends on the type and concentration of paraben present in the OTC topical products. While the capacity for these OTC topical medications to induce estrogen activity in individuals using the products is unclear, consumers may benefit from more information about the paraben type and concentration present. Oxford University Press 2021-05-03 /pmc/articles/PMC8089598/ http://dx.doi.org/10.1210/jendso/bvab048.995 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Endocrine Disruption
Allen, Brianna
Ma, Peng
Zhang, Changde
Wiese, Thomas E
Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration
title Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration
title_full Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration
title_fullStr Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration
title_full_unstemmed Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration
title_short Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration
title_sort estrogen activity of otc topical medications containing parabens depends on paraben type and concentration
topic Endocrine Disruption
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089598/
http://dx.doi.org/10.1210/jendso/bvab048.995
work_keys_str_mv AT allenbrianna estrogenactivityofotctopicalmedicationscontainingparabensdependsonparabentypeandconcentration
AT mapeng estrogenactivityofotctopicalmedicationscontainingparabensdependsonparabentypeandconcentration
AT zhangchangde estrogenactivityofotctopicalmedicationscontainingparabensdependsonparabentypeandconcentration
AT wiesethomase estrogenactivityofotctopicalmedicationscontainingparabensdependsonparabentypeandconcentration